Cargando…
Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?
Langerhans cell histiocytosis (LCH) is due to aberrant monoclonal proliferation and accumulation of dendritic cells, ranging from a self-limiting local condition to a rapidly progressive multisystem disease with poor prognosis. Pathogenic cells originate from a myeloid-derived precursor characterize...
Autores principales: | Gaspari, Stefania, Di Ruscio, Valentina, Stocchi, Francesca, Carta, Roberto, Becilli, Marco, De Ioris, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710608/ https://www.ncbi.nlm.nih.gov/pubmed/34966688 http://dx.doi.org/10.3389/fonc.2021.794498 |
Ejemplares similares
-
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study
por: Donadieu, Jean, et al.
Publicado: (2019) -
Multisystem Langerhans Cell Histiocytosis in Adult
por: Garg, Anubhav, et al.
Publicado: (2012) -
Multisystemic Langerhans cell histiocytosis in an adult
por: Hegemann, Marie-Valerie, et al.
Publicado: (2017) -
Multisystem Langerhans Cell Histiocytosis in an infant
por: Ji, William, et al.
Publicado: (2021) -
Multisystem involvement of Langerhans cell histiocytosis in an adult
por: Samanci, Nilay Sengul, et al.
Publicado: (2019)